SupplierRadar

Suzhou Fushilai Pharmaceutical Co., Ltd.

FDA import alert and refusal historyChangshu, ChinaFEI 3003898203

Watch this supplier

Watch this supplier

Get an email when FDA publishes anything new on Suzhou Fushilai Pharmaceutical Co., Ltd..

Enter your work email and confirm with the link we send. Your first supplier is free, with no password and no card.

Example subjectSuzhou Fushilai Pharmaceutical Co., Ltd added to Import Alert 16-129 (red list)

Free for one supplier. No password, no card.

As of October 26, 2026, Suzhou Fushilai Pharmaceutical Co., Ltd. is not on any FDA import alert in SupplierRadar's records; FDA refused 2 of its shipment lines between March 26, 2020 and June 26, 2023, most often for dirsexmpt (DIRSEXMPT).

Data from FDA public records, last checked . Request a correction

Current status

Import alerts
Not listed
Last import refusal
Vitamin, mineral, proteins and unconventional dietary specialities for humans and animals, n.e.c. · NOT LISTED
Last warning letter
None found
Last inspection
Classified VAI (Voluntary Action Indicated)

Every FDA record for Suzhou Fushilai Pharmaceutical Co., Ltd.

4 records, newest first. Each line links to the FDA page it came from.

2023

  1. Import refusal
    Refused, Vitamin, mineral, proteins and unconventional dietary specialities for humans and animals, n.e.c.NOT LISTEDFRNMFGREGEntry 024-1650269-4
    Source

2021

  1. Inspection
    Inspection classified VAI (Voluntary Action Indicated)Food Composition, Standards, Labeling and Econ; Foodborne Biological Hazards
    Source

2020

  1. Import refusal
    Refused, Herbals & botanicals (not teas), n.e.c.DIRSEXMPTEntry SCS-8922478-7
    Source

2014

  1. Inspection
    Inspection classified NAI (No Action Indicated)Foodborne Biological Hazards
    Source

Refusal charges, in plain English

  • DIRSEXMPT1 refused line

    DIRSEXMPT

  • FRNMFGREG1 refused line

    FRNMFGREG

  • NOT LISTED1 refused line

    Product not listed with FDA

    The product appeared to be a drug or device that is not included in the listing FDA requires under section 510(j) of the FD&C Act.

Questions about Suzhou Fushilai Pharmaceutical Co., Ltd.

Is Suzhou Fushilai Pharmaceutical Co., Ltd. on an FDA import alert?
No listing for Suzhou Fushilai Pharmaceutical Co., Ltd. appears in the FDA import alerts SupplierRadar checked on October 26, 2026. Country-wide alerts may still apply to its products; see the China page.
Has FDA refused shipments from Suzhou Fushilai Pharmaceutical Co., Ltd.?
Yes. FDA refused 2 shipment lines from Suzhou Fushilai Pharmaceutical Co., Ltd. between March 26, 2020 and June 26, 2023. The most recent, on June 26, 2023, was vitamin, mineral, proteins and unconventional dietary specialities for humans and animals, n.e.c., charged as NOT LISTED (product not listed with fda).
Why did FDA refuse Suzhou Fushilai Pharmaceutical Co., Ltd.'s shipments?
The most frequent charges are DIRSEXMPT (dirsexmpt, 1 line) and FRNMFGREG (frnmfgreg, 1 line).
When was Suzhou Fushilai Pharmaceutical Co., Ltd. last inspected by FDA?
FDA's most recent inspection of Suzhou Fushilai Pharmaceutical Co., Ltd. with a final classification is dated March 26, 2021 and was classified VAI (Voluntary Action Indicated).
What is Suzhou Fushilai Pharmaceutical Co., Ltd.'s FEI number?
Suzhou Fushilai Pharmaceutical Co., Ltd.'s FDA Establishment Identifier (FEI) is 3003898203.

Buying from Suzhou Fushilai Pharmaceutical Co., Ltd.?

Watch it and get the FDA record the day it changes. Free for one supplier.

Watch this supplier

Watch this supplier

Get an email when FDA publishes anything new on Suzhou Fushilai Pharmaceutical Co., Ltd..

Enter your work email and confirm with the link we send. Your first supplier is free, with no password and no card.

Example subjectSuzhou Fushilai Pharmaceutical Co., Ltd added to Import Alert 16-129 (red list)

Free for one supplier. No password, no card.

SupplierRadar is not affiliated with the U.S. Food and Drug Administration. Data comes from public FDA records and may contain errors. This is not legal advice; importers remain responsible for their supplier evaluations.